हिंदी में पढ़ें
Banking & Financial Services
Income Tax Calculator
Personal Loan Calculator
Car Loan Calculator
Home Loan Calculator
Non-price control medicines price to get reduced
Wed, Nov 27, 2019
Non-price control medicines price to get reduced. Watch this video to know more.
Indian healthcare may grow threefold to $372 billion by 2022: Assocham
Sun, Dec 03, 2017
The Indian healthcare market is likely to reach $372 billion by 2022 in a threefold growth in value terms, industry chamber Assocham said on Sunday, citing its latest study on the subject.
Panacea Biotec signs seven drugs deal with Bionpharma Inc
Fri, Jul 28, 2017
Key Highlights 7 drugs represent a total estimated market potential of more than $800 million
Dr Reddy's Laboratories Q4 review: Here's what to expect
Fri, May 12, 2017
In Q3FY17, the company reported consolidated net profit of Rs 492.3 crore, down 15.94% year-on-year compared to Rs 585.7 crore in the corresponding period of the previous year.
We have a wide trade deficit with China, says Shaktikanta Das
Mon, Feb 13, 2017
Shaktikanta Das said that they are working to increase their exports in China and to decrease the trade deficit.
GlaxoSmithKline Pharma's Q3 net profit down 33%
Sat, Feb 11, 2017
The company reported net profit of Rs 52.95 crore, a drop of 32.91% from Rs 78.93 crore in the corresponding period of the previous year.
Lupin's Q3 net profit rise by 21%; shares trade high
Thu, Feb 09, 2017
Pharmaceutical-major Lupin on Thursday reported 21% rise in net profit during the quarter ended on December 31.
Q3FY17: Dr Reddy's Laboratories' net profit down 19% at Rs 470 crore
Sat, Feb 04, 2017
GV Prasad, Co-chairman of Dr Reddy's Laboratories said, "Our performance in Q3 has delivered a modest sequential revenue growth of 3% over the previous quarter. Our EBITDA has improved significantly from the last quarter to Rs 8.8 billion, on the back of enhanced emphasis on operational efficiencies and controlling of SG&A cost across all our business."
Divi's Laboratories report 9% rise in net profit in Q3
Sat, Feb 04, 2017
Updating on US-FDA inspection, Divi's Lab said, "It has filed its comprehensive response to the observations of the FDA regulator within the stipulated time. Now it awaits for review from the US pharma regulator.
Glenmark Pharma's Q3 net profit rise by 143% to Rs 477 crore
Thu, Feb 02, 2017
The company's total income increased to Rs 2549.5 crore in Q3FY17 as compared to Rs 1780.4 crore in Q3FY16.
Natco Pharma drops as USFDA makes six observations
Wed, Jan 25, 2017
Shares of Natco Pharma dropped 0.22% on NSE Nifty after the company said that USFDA conducted an inspection at its pharmaceutical factory in Kothur, near Hyderabad between January 16-24, 2017.
Pharma Q3: FDA inspection, US pricing market key
Thu, Jan 12, 2017
Piyush Nahar and Anurag Mantry analysts of Jefferies said, “We expect another muted quarter for the pharma sector led by weakness in US business. USFDA inspections and pricing in US market will continue to dominate the results. Recent comments from global peers have indicated that pricing scenario will likely remain unchanged in 2017.”
Zydus Cadila acquires six brands from American pharma MSD
Wed, Dec 28, 2016
Though the companies have not disclosed the financial details of the deal.
Divi's laboratories drops over 10% on USFDA reports
Mon, Dec 26, 2016
Pharmaceutical major Divi's Laboratories Ltd continued to fall on Monday with the stock cracking over 10%, or Rs 85.75 per share.
Sun Pharma arm picks up 14.6% stake in US company for $13 million
Fri, Dec 23, 2016
"...One of the wholly-owned subsidiaries of the company has acquired 13,000,000 Series B preferred stock of scPharmaceuticals Inc (equivalent to 14.58% fully diluted equity stake on conversion) by way of allotment," Sun Pharmaceutical Industries said in a BSE filing.
Sun Pharma to acquire oncology product from Novartis for $175 million; stock up 0.5%
Thu, Dec 22, 2016
"Odomzo gives us an opportunity to meaningfully expand our already established branded dermatology business and support our expansion into branded oncology with a launched brand," Kirti Ganorkar, Global Head Business Development at Sun Pharma, said.
Fire accident at Biocons' one Syngene Lab, shares tumble
Tue, Dec 13, 2016
It said, "Syngene is in the process of assessing the extent of damage to the building and equipment and also implementating a business continuity plan to minimize impact on operations."
M&A activity to fuel growth for India's pharma sector
Mon, Dec 12, 2016
Kaustubh Chaubal, a Moody's Vice President and Senior Analyst said, "The drive for overseas expansion comes amid the consolidation of the global pharmaceutical industry, as drug companies look to boost their product and pipeline diversity, scale and pricing power."
Indian pharma industry facing growth headwinds: ICRA
Thu, Dec 08, 2016
"In spite of these ongoing challenges, several Indian pharma companies are increasing their R&D spend, targeting pipeline of specialty drugs, niche molecules and complex therapies," ICRA said.
Sun Pharma to acquire Russia's JSC Biosintez; shares up
Wed, Nov 23, 2016
“With this move, we plan to acquire the product portfolio and local manufacturing capability in Russia which would help in expanding our presence in Russia and serving Russia pharmaceutical market more effectively,” Sun Pharma said in a statement.